scispace - formally typeset
L

Lijun Chen

Researcher at Johns Hopkins University

Publications -  34
Citations -  3215

Lijun Chen is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Glycosylation & Glycoprotein. The author has an hindex of 16, co-authored 28 publications receiving 1816 citations. Previous affiliations of Lijun Chen include Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

David J. Clark, +224 more
- 31 Oct 2019 - 
TL;DR: A large-scale proteogenomic analysis of ccRCC is reported to discern the functional impact of genomic alterations and provides evidence for rational treatment selection stemming fromccRCC pathobiology.
Journal ArticleDOI

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Michael A. Gillette, +189 more
- 09 Jul 2020 - 
TL;DR: Comprehensive proteogenomic characterization of 110 tumors and 101 matched normal adjacent tissues (NATs) incorporating genomics, epigenomics, deep-scale proteomics, phosphoproteomics, and acetylproteomics identified therapeutic vulnerabilities associated with driver events involving KRAS, EGFR, and ALK.
Journal ArticleDOI

Proteogenomic Characterization of Endometrial Carcinoma.

Yongchao Dou, +219 more
- 20 Feb 2020 - 
TL;DR: A comprehensive proteogenomic characterization of endometrial carcinomas revealed possible new consequences of perturbations to the p53 and Wnt/β-catenin pathways, identified a potential role for circRNAs in the epithelial-mesenchymal transition, and provided new information about proteomic markers of clinical and genomic tumor subgroups, including relationships to known druggable pathways.